Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK7 | Q13164 | 12/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | KIT | P10721 | 2/20 | 0.41 |
| ▸ | AURKA | O14965 | 2/20 | 0.39 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.39 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21821706 | 0.85 | MAPK7 (0.44) | MAPK7KDM4EKITAURKAENPP1 | |
| SCHEMBL29582405 | 0.81 | HTR4 (0.39) | — | |
| SCHEMBL29583029 | 0.75 | TP53 (0.48) | — | |
| SCHEMBL22300105 | 0.74 | MAPK7 (0.56) | MAPK7KDM4EAURKAENPP1 | |
| SCHEMBL29581982 | 0.73 | TLR9 (0.39) | — | |
| SCHEMBL22291002 | 0.71 | ENPP1 (0.58) | MAPK7ENPP1 | |
| SCHEMBL29857667 | 0.71 | ENPP1 (0.58) | MAPK7ENPP1 | |
| SCHEMBL20797981 | 0.71 | MAPK7 (0.52) | MAPK7ENPP1 | |
| SCHEMBL30776980 | 0.71 | MAPK7 (0.52) | MAPK7ENPP1 | |
| SCHEMBL20813639 | 0.71 | MAPK7 (0.54) | MAPK7ENPP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11319303-B2 | Compound used as autophagy regulator, and preparation method therefor and uses thereof | Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) | 2022-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11319303-B2 | Compound used as autophagy regulator, and preparation method therefor and uses thereof | ATG7, SQSTM1, BECN1 | MAPK7 644/4885KDM4E 2846/4885KIT 1937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.